Is There A Cannabis Dispensary Near Chicago’s Wrigley Field?

“This is a one-of-a-kind Sunnyside that will better accommodate our existing patients and consumers and act as a showcase for the millions of visitors to the Wrigleyville neighborhood each year. It will feature unique product activations, 21 points of sale and plenty of space to serve patients and customers on high-traffic days when baseball games, concerts and large-scale events are taking place next door,” said Charlie Bachtell, Cresco Labs’ CEO & Co-founder. “To think back on when the original Wrigleyville location opened for medical sales five years ago, it’s incredible to see how far this industry and organization has come and to see the outstanding execution from our retail team.”

Cresco Labs relocated its Sunnyside dispensary two blocks south to 3524 N. Clark St., the former site of Chicago’s celebrated John Barleycorn bar. Sunnyside Wrigleyville is located along one of Chicago’s busiest entertainment corridors featuring nearly 50 bars and restaurants and dozens of shops and businesses. The 10,000 sq. ft. store has nearly 5,500 sq. feet of retail space to provide an enhanced consumer experience and the ability for wellness advisors to better serve the needs of medical patients and consumers. Sunnyside opened as a medical dispensary at its previous location about five years ago and has been operating as a dual-purpose dispensary since Illinois’ launch of adult-use cannabis sales in January 2020. The new location will continue to prioritize medical cannabis patients with express entry and dedicated points of sale.

Sunnyside Wrigleyville offers the widest selection of premium products from Cresco Labs’ House of Brands and other top cannabis brands. Items available for sale include flower, vapes, edibles, pre-rolls, concentrates, topicals, captures, tinctures, beverages, accessories and branded merchandise. Medical patients and adult-use customers have the option to place orders online through the Sunnyside.shop website, in store by speaking with wellness advisors or via phone by calling 773-820-7280. Store hours are Sunday to Saturday from 9:00 AM to 9:00 PM.

The original Sunnyside Lakeview location will be redeveloped as the Illinois Cannabis Education Center – a hands-on destination for people who have been adversely impacted by the War on Drugs to develop the skills necessary to successfully operate a compliant dispensary.

For more information about Sunnyside, visit www.sunnyside.shop.

About Cresco Labs Inc.

Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy’s Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.

Forward Looking Statements

This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as, ‘may,’ ‘will,’ ‘should,’ ‘could,’ ‘would,’ ‘expects,’ ‘plans,’ ‘anticipates,’ ‘believes,’ ‘estimates,’ ‘projects,’ ‘predicts,’ ‘potential’ or ‘continue’ or the negative of those forms or other comparable terms. The Company’s forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to those risks discussed under “Risk Factors” in the Company’s Annual Information Form for the year ended December 31, 2020 filed on March 26, 2021, and other documents filed by the Company with Canadian securities regulatory authorities; and other factors, many of which are beyond the control of the Company. Readers are cautioned that the foregoing list of factors is not exhaustive. Because of these uncertainties, you should not place undue reliance on the Company’s forward-looking statements. No assurances are given as to the future trading price or trading volumes of Cresco Labs’ shares, nor as to the Company’s financial performance in future financial periods. The Company does not intend to update any of these factors or to publicly announce the result of any revisions to any of the Company’s forward-looking statements contained herein, whether as a result of new information, any future event or otherwise. Except as otherwise indicated, this press release speaks as of the date hereof. The distribution of this press release does not imply that there has been no change in the affairs of the Company after the date hereof or create any duty or commitment to update or supplement any information provided in this press release or otherwise.